Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 11, 2010, Pages 1814-1821

  Cui, Yanji ^a   Wu, Jinji ^a   Jung, Sung Cherl ^a   Park, Deok Bae ^a   Maeng, Young Hee ^a   Hong, Jeong Yun ^a   Kim, Se Jae ^b   Lee, Sun Ryung ^b   Kim, Soon Jong ^c   Kim, Sang Jeong ^d   Eun, Su Yong ^a  

^a Jeju National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

^c Mokpo National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Citrus; Microglia; Neurodegeneration; Neuroinflammation; Nobiletin; Nuclear factor B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NOBILETIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL NUCLEUS; CELL STIMULATION; CITRUS FRUIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DEGENERATIVE DISEASE; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; MICROGLIA; MOLECULAR MECHANICS; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; CELL NUCLEUS; CITRUS; CYTOKINES; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MINOCYCLINE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 78249239462     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1814     Document Type: Article

References (44)

1. Christensen D. Z., Bayer T. A., Wirths O., Neurobiol. Aging, 31, 1153-1163 (2008).
2. Wu C. K., Thal L., Pizzo D., Hansen L., Masliah E., Geula C., Exp. Neurol., 195, 484-496 (2005).
3. Caudle W. M., Zhang J., Exp. Neurol., 220, 230-233 (2009).
4. Lees A. J., Hardy J., Revesz T., Lancet, 373, 2055-2066 (2009).
5. Van Damme P., Robberecht W., Curr. Opin. Neurol., 22, 486-492 (2009).
6. Ochfeld E., Newhart M., Molitoris J., Leigh R., Cloutman L., Davis C., Crinion J., Hillis A. E., Stroke, 41, 325-330 (2010).
7. Wang Y. D., Li X. P., Li M., Liu S., Lu X. P., Peng Y., Huang R. X., Eur. Neurol., 63, 52-59 (2009).
8. Cho I. H., Hong J., Suh E. C., Kim J. H., Lee H., Lee J. E., Lee S., Kim C. H., Kim D. W., Jo E. K., Lee K. E., Karin M., Lee S. J., Brain, 131, 3019-3033 (2008).
9. Rupalla K., Allegrini P. R., Sauer D., Wiessner C., Acta Neuropathol., 96, 172-178 (1998).
10. Zhang Z., Chopp M., Powers C., Brain Res., 744, 189-198 (1997).
11. Park G. H., Jeon S. J., Ko H. M., Ryu J. R., Lee J. M., Kim H. Y., Han S. H., Kang Y. S., Park S. H., Shin C. Y., Ko K. H., Nitric Oxide, 22, 18-29 (2010).
12. Ock J., Kim S., Yi K. Y., Kim N. J., Han H. S., Cho J. Y., Suk K., Biochem. Pharmacol., 79, 596-609 (2010).
13. Tikka T., Fiebich B. L., Goldsteins G., Keinanen R., Koistinaho J., J. Neurosci., 21, 2580-2588 (2001).
14. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P. H., Koistinaho J., Proc. Natl. Acad. Sci. U.S.A., 96, 13496-13500 (1999).
15. Breitner J. C., Gau B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J., Anthony J. C., Neurology, 44, 227-232 (1994).
16. Combs C. K., Johnson D. E., Karlo J. C., Cannady S. B., Landreth G. E., J. Neurosci., 20, 558-567 (2000).
17. Kim H. S., Suh Y. H., Behav. Brain Res., 196, 168-179 (2009).
18. Lu L., Li F., Wang X., CNS Neurol. Disord. Drug Targets, 9, 232-240 (2009).
19. Choi S. Y., Hwang J. H., Ko H. C., Park J. G., Kim S. J., J. Ethnopharmacol., 113, 149-155 (2007).
20. Choi S. Y., Ko H. C., Ko S. Y., Hwang J. H., Park J. G., Kang S. H., Han S. H., Yun S. H., Kim S. J., Biol. Pharm. Bull., 30, 772-778 (2007).
21. Nagase H., Omae N., Omori A., Nakagawasa O., Tadano T., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., Biochem. Biophys. Res. Commun., 337, 1330-1336 (2005).
22. Nakajima A., Yamakuni T., Haraguchi M., Omae N., Song S. Y., Kato C., Nakagawasai O., Tadano T., Yokosuka A., Mimaki Y., Sashida Y., Ohizumi Y., J. Pharmacol. Sci., 105, 122-126 (2007).
23. Onozuka H., Nakajima A., Matsuzaki K., Shin R. W., Ogino K., Saigusa D., Tetsu N., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., J. Pharmacol. Exp. Ther., 326, 739-744 (2008).
24. Yamamoto Y., Shioda N., Han F., Moriguchi S., Nakajima A., Yokosuka A., Mimaki Y., Sashida Y., Yamakuni T., Ohizumi Y., Fukunaga K., Brain Res., 1295, 218-229 (2009).
25. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F., J. Neuroimmunol., 27, 229-237 (1990).
26. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., Kettenmann H., J. Neurosci. Res., 31, 616-621 (1992).
27. Eun S. Y., Kim E. H., Kang K. S., Kim H. J., Jo S. A., Kim S. J., Jo S. H., Kim S. J., Blackshear P. J., Kim J., Exp. Mol. Med., 38, 310-319 (2006).
28. Min K. J., Pyo H. K., Yang M. S., Ji K. A., Jou I., Joe E. H., Glia, 48, 197-206 (2004).
29. Ock J., Kim S., Suk K., Pharmacol. Res., 59, 414-422 (2009).
30. Eun S. Y., Hong Y. H., Kim E. H., Jeon H., Suh Y. H., Lee J. E., Jo C., Jo S. A., Kim J., Biochem. Biophys. Res. Commun., 325, 320-327 (2004).
31. Choi S. H., Joe E. H., Kim S. U., Jin B. K., J. Neurosci., 23, 5877-5886 (2003).
32. Ryu J., Pyo H., Jou I., Joe E., J. Biol. Chem., 275, 29955-29959 (2000).
33. Pyo H., Joe E., Jung S., Lee S. H., Jou I., J. Biol. Chem., 274, 34584-34589 (1999).
34. Combs C. K., Karlo J. C., Kao S. C., J. Neurosci., 21, 1179-1188 (2001).
35. Kaushal V., Schlichter L. C., J. Neurosci., 28, 2221-2230 (2008).
36. Parameshwaran K., Dhanasekaran M., Suppiramaniam V., Exp. Neurol., 210, 7-13 (2008).
37. Min S. S., Quan H. Y., Ma J., Han J. S., Jeon B. H., Seol G. H., Neurosci. Lett., 456, 20-24 (2009).
38. Rosi S., Ramirez-Amaya V., Hauss-Wegrzyniak B., Wenk G. L., J. Neuroinflammation, 1, 12 (2004).
39. Min S. S., Quan H. Y., Ma J., Lee K. H., Back S. K., Na H. S., Han S. H., Yee J. Y., Kim C., Han J. S., Seol G. H., Biochem. Biophys. Res. Commun., 383, 93-97 (2009).
40. Breitner J. C., Haneuse S. J., Walker R., Dublin S., Crane P. K., Gray S. L., Larson E. B., Neurology, 72, 1899-1905 (2009).
41. in t' Veld B. A., Ruitenberg A., Hofman A., Launer L. J., van Duijn C. M., Stijnen T., Breteler M. M., Stricker B. H., N. Engl. J. Med., 345, 1515-1521 (2001).
42. Szekely C. A., Thorne J. E., Zandi P. P., Ek M., Messias E., Breitner J. C., Goodman S. N., Neuroepidemiology, 23, 159-169 (2004).
43. Matsuzaki K., Miyazaki K., Sakai S., Yawo H., Nakata N., Moriguchi S., Fukunaga K., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., Eur. J. Pharmacol., 578, 194-200 (2008).
44. Nakajima A., Yamauni T., Matsuzaki K., Nakata N., Onozuka H., Yokosuka A., Sashida Y., Mimaki Y., Ohizumi Y., J. Pharmacol. Exp. Ther., 321, 784-790 (2007).